If you need more lookups,
subscriptions start at $34 USD/month.
Frank Torti Location
United States
Frank Torti Work
Vant Chair and President @ (August 2018 - Present)
Executive Chairman @ (August 2021 - Present)
Executive Chairman @ (June 2022 - Present)
CEO and Chairman @ Telavant (Acquired by Roche for $7.25B) (January 2022 - January 2024)
Partner @ (January 2007 - January 2018)
Frank Torti Education
UNC School of Medicine
MD
Harvard Business School
MBA
Frank Torti Skills
Enterprise Software
Research
Sales
Venture Capital
Private Equity
Frank Torti Summary
Frank Torti, based in United States, is currently a Vant Chair and President at Roivant Sciences. Frank Torti brings experience from previous roles at Immunovant, Priovant Therapeutics, Telavant (Acquired by Roche for $7.25B) and New Enterprise Associates. Frank Torti holds a MD @ UNC School of Medicine. With a robust skill set that includes Enterprise Software, Research, Sales, Venture Capital, Private Equity and more. Frank Torti has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Frank Torti?
Find contact details for 700 million professionals.